FDA Device Intelligence
Home › DRG Instruments Gesellschaft mit beschränkter Haftung › Coxiella burnetii (Q-Fever) Phase 1 IgG ELISA

Coxiella burnetii (Q-Fever) Phase 1 IgG ELISA

DRG Instruments Gesellschaft mit beschränkter Haftung · Model EIA-5188 · UDI-DI 04048474051889

GPR Prescription
0
510(k) clearances
0
Adverse events
0
Recalls
4
Facilities

Description

The Coxiella burnetii (Q-Fever) Phase 1 IgG ELISA is intended for the qualitative determination of IgG class antibodies against Coxiella burnetii (Q-Fever) Phase 1 in human serum or plasma (citrate, heparin).

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.